Heuristik key facts
as of Oct 2026- Developer of a patient identification and management technology designed to increase the efficiency of patient identification.
- Heuristik is valued at approximately $4.0M as of Oct 2026 (last reported valuation).
- It has raised $1.1M; the latest was Later Stage VC in Dec 2025.
- Notable investors include MassChallenge, University of Oxford, Massachusetts Institute of Technology, Caelestinus, Neotec Capital Riesgo — 21 tracked in total.
- Status: Privately Held (backing).
Heuristik's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch Heuristik: the Monday email on marks, rounds and moves
Heuristik funding rounds
No funding rounds for Heuristik are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Heuristik
21+Heuristik valuation
Heuristik's last reported valuation was $4 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Heuristik investors
21 investors are on record for Heuristik, including MassChallenge, University of Oxford, Massachusetts Institute of Technology and Caelestinus.
About Heuristik
Developer of a patient identification and management technology designed to increase the efficiency of patient identification. The company's technology combines biometrics and artificial intelligence that identify fingerprints and patient information and management of medical records, enabling healthcare entities to reduce costs, streamline patient identification and management processes, favor interoperability, reduce fraud, and improve the patient experience.
- Sector
- Healthcare
- HQ
- Getxo, Spain
- Founded
- 2019
- Employees
- 13
- Website
- heuristik.tech/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.